These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 23266055

  • 1. Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.
    Schiffer JM, Maniatis P, Garza I, Steward-Clark E, Korman LT, Pittman PR, Mei JV, Quinn CP.
    Biologicals; 2013 Mar; 41(2):98-103. PubMed ID: 23266055
    [Abstract] [Full Text] [Related]

  • 2. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.
    J Immunol Methods; 2012 Feb 28; 376(1-2):97-107. PubMed ID: 22197974
    [Abstract] [Full Text] [Related]

  • 3. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
    Ghosh N, Gunti D, Lukka H, Reddy BR, Padmaja J, Goel AK.
    Indian J Med Res; 2015 Aug 28; 142(2):196-204. PubMed ID: 26354217
    [Abstract] [Full Text] [Related]

  • 4. Ability of ELISA and a toxin neutralization assay to detect changes in immunogenicity of a recombinant Bacillus anthracis protective antigen vaccine upon storage.
    Domínguez-Castillo RI, Verma A, Amador-Molina JC, Sirota L, Arciniega JL.
    Biologicals; 2013 Mar 28; 41(2):111-4. PubMed ID: 23137818
    [Abstract] [Full Text] [Related]

  • 5. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
    Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.
    Emerg Infect Dis; 2002 Oct 28; 8(10):1103-10. PubMed ID: 12396924
    [Abstract] [Full Text] [Related]

  • 6. Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    Zorigt T, Furuta Y, Simbotwe M, Ochi A, Tsujinouchi M, Shawa M, Shimizu T, Isoda N, Enkhtuya J, Higashi H.
    PLoS One; 2021 Oct 28; 16(10):e0258317. PubMed ID: 34634075
    [Abstract] [Full Text] [Related]

  • 7. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.
    FEMS Immunol Med Microbiol; 2009 Nov 28; 57(2):165-72. PubMed ID: 19732139
    [Abstract] [Full Text] [Related]

  • 8. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine.
    Lininger LA, Cullum ME, Lyles MB, Bienek DR.
    Vaccine; 2007 Feb 19; 25(9):1619-25. PubMed ID: 17150286
    [Abstract] [Full Text] [Related]

  • 9. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Bienek DR, Chang CK, Cohen ME.
    Vaccine; 2007 Aug 10; 25(32):5978-84. PubMed ID: 17597265
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
    Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Snawder JE, Robertson SA, Quinn CP.
    Clin Vaccine Immunol; 2006 May 10; 13(5):541-6. PubMed ID: 16682473
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity.
    Shlyakhov E, Shoenfeld Y, Gilburd B, Rubinstein E.
    Clin Microbiol Infect; 2004 May 10; 10(5):421-4. PubMed ID: 15113319
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.
    FEMS Immunol Med Microbiol; 2012 Aug 10; 65(3):505-9. PubMed ID: 22515653
    [Abstract] [Full Text] [Related]

  • 17. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 18. Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.
    Semenova VA, Steward-Clark E, Maniatis P, Epperson M, Sabnis A, Schiffer J.
    Biologicals; 2017 Jan 01; 45():61-68. PubMed ID: 27814939
    [Abstract] [Full Text] [Related]

  • 19. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
    Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.
    Microb Pathog; 2005 Jan 01; 38(1):33-40. PubMed ID: 15652293
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.